Stephen,
As you have said,  "The much too little legitimate research into CS is
due to 'scientific' and 'official' scepticism. And this is due to the
lack of consistent [even minimal] quality of commercial products that
have opportunistically capitalized on the small body of legitimate
research that does exist...."  This last bit doesn't sound right to me.
Haven't others here been consistently saying that the folks who make the
drugs have too much invested in the conventional anti biotics to see
something like CS succeed? As simplistic as it may sound, these
companies would be throwing away $Billions annually because people can
buy CS inexpensively. Why do you blame this on current producers? Surely
this problem goes back to 1938 and before.
Reid


--
The silver-list is a moderated forum for discussion of colloidal silver.

To join or quit silver-list or silver-digest send an e-mail message to: 
[email protected]  -or-  [email protected]
with the word subscribe or unsubscribe in the SUBJECT line.

To post, address your message to: [email protected]
Silver-list archive: http://escribe.com/health/thesilverlist/index.html
List maintainer: Mike Devour <[email protected]>